hplc2010 pharmaceutical copolymer excipient characterization by gpc-ftir

40
Pharmaceutical Copolymer Excipient Characterization by SEC/GPC-FTIR William W. Carson ; David Dunn; Jim Dwyer; Ming Zhou; Tom Kearney Spectra Analysis Instruments, Inc. June 20, 2010 Contact: [email protected] 1 HPLC 2010 Boston: P2062T

Upload: mzhou45

Post on 01-Jul-2015

955 views

Category:

Documents


0 download

DESCRIPTION

HPLC2010 Boston Presentation

TRANSCRIPT

Page 1: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

Pharmaceutical Copolymer Excipient

Characterization by SEC/GPC-FTIR

William W. Carson; David Dunn; Jim Dwyer;

Ming Zhou; Tom Kearney

Spectra Analysis Instruments, Inc.

June 20, 2010

Contact: [email protected]

1

HPLC 2010 Boston: P2062T

Page 2: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

LC-IR Hyphenation

Page 3: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

Direct Deposition FTIR withDots (HPLC-IR) and Narrow Films (GPC-IR)

Page 4: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

Direct Deposition FTIR &

Data Processing (GPC-IR)

Page 5: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

GPC-IR Hyphenated Technology: 3D Plot

to Map out Polymer Compositions with Sizes

5

Page 6: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

Excipient Characterization by GPC-IR

6

Copolymer Compositional Analysis with MW Distributions

• Comonomer Ratio Drift (Functional Groups) vs. Bulk Average

• Excipient Lot-to-Lot Variations: QbD Studies

Excipient Performance & Functional Group Correlations

• Hydrophobic/Hydrophilic Ratio Drift vs. Phase Separations

• Effects on Excipient Dissolution Behavior

Reference

(1) Chemical Heterogeneity on Dissolution of HPMC,

EU J. of Pharma Sci., P392 (2009), A. Viriden et al.

(2) Comp Drift Effect on Dissolution of PMMA/MAA,

Materials Letters, P1144 (2009), E. Manias et al.

Page 7: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

IR Spectrum of Copovidone Excipient –

VP/VAc Copolymer from GPC-IR

Peak 1680 cm-1 from VP comonomer

Peak 1740 cm-1 from VAc comonomer

Page 8: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

GPC-IR Chromatogram Overlay with Comonomer Ratios

Excipient Compositional Drift (IR Peak Ratios)

with MWD Vs. Bulk Average

Abs. Peak Ratio: AVA / AVP = (k1*b*MVA) / (k2*b*MVP) = k (MVA / MVP) ~ Comonomer Ratio

(Molecular Weight Distribution)

Bulk Average

Copovidone

Page 9: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

0

.1

.2

.3

.4

.5

.6

106 104 103 102105

ma

x. IR

ab

so

rba

nce

Molecular Weight

Copovidone: sample A

30

35

40

45

50

molecular weight

distribution

% a

ceta

te c

om

onom

er

comonomer composition

distribution

Excipient Compositional Drift (%VAc)

with MWD Vs. Bulk Average

Bulk Average

40% VAc

Page 10: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

0

.1

.2

.3

.4

.5

.6

106 104 103 102105 Molecular Weight

Copovidone: sample A

30

35

40

45

50 % a

ceta

te c

om

onom

er

Comonomer Composition

Distribution

sample B

sample C

0

.1

.2

.3

.4

.5

.6

106 104 103 102105

sample B

sample C

Bulk 40% VAc

ma

x. IR

ab

so

rba

nce Molecular Weight

Distribution

Copovidone Compositional Drifts (%VAc)

from Different Manf. Processes

Copovidone A gave clear tablets while Copovidone C led to cloudy ones.

Page 11: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

IR Spectrum Difference of Two Grades of HPMC

(Type 2910 & 2208) from GPC-IR

OH

CH2

HP

CH3OCH3

CH2

-C-O-C-

Page 12: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

HPMCAS Grade-to-Grade

Difference (LF, MF, HF) by GPC-IR

M

OCH3

2830

C/HP

OH

3470

HP

CH3

1372

A

Acetyl

1235

AS

C=O

1740

HOOC-CH2-CH2-C=O

CH3-C=O

-C-O-C-Backbone

Ether

1060

Page 13: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

IR Band Identifications of HPMCAS Excipient

CH3-C=O

HOOC-CH2-CH2-C=O

Groups HP M C A AS Notes

CH3 1372 HP

OCH3 2830 M

OH 3470 (Unsub. OH & HP OH) OH

COCH3 1235 A

Total C=O 1740 AS

CH2 2935 2935 2935 2935 CH2

C-O-C 1060 BackBone

(BB)

Page 14: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

GPC-IR Chromatograph & Spectra of

HPMCAS Sample

Page 15: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

GPC-IR Chromatogram Overlay at

Different Wavenumbers of 2 HPMCAS Samples

ES1:

1060 cm-1

2834 cm-1

2838 cm-1

2935 cm-1

SE2:

1060 cm-1

2834 cm-1

2838 cm-1

2935 cm-1

Page 16: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

Acetyl/Backbone Ratio Drifts of 2 HPMCAS

Samples with Elution Time (MWD)

ES1SE2

Page 17: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

Total C=O AS / Backbone Ratio Drifts of 2 HPMCAS

Samples with Elution Time (MWD)

SE2

ES1

Page 18: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

To Find Succinic Acid Level on Backbone

(AS/Backbone)- k (A/Backbone) => S / Backbone

Absorptivity Ratio k

Needs to be Calibrated

from Known Standards

AS / BB Ratios

A / BB Ratios

ES1

SE2

ES1

SE2

Page 19: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

HP/Backbone Ratio Drifts of 2 HPMCAS

Samples with Elution Time (MWD)

ES1

SE2

Page 20: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

Total OH/Backbone Ratio Drifts of 2 HPMCAS

Samples with Elution Time (MWD)

ES1

SE2

Page 21: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

To Find Unsubstituted OH on Backbone

(OH/Backbone)- k (HP/Backbone) => Unsub. OH / Backbone

Absorptivity Ratio k Needs to be Calibrated from

Known Standards

SE2

ES1

ES1

SE2

HP / BB Ratios

OH / BB Ratios

Page 22: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

Methoxy / Backbone Ratio Drifts of 2 HPMCAS

Samples with Elution Time (MWD)

SE2

ES1

Page 23: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

2935cm-1 CH2 / Backbone Ratio Drifts of

2 HPMCAS Samples with Elution Time (MWD)

ES1

SE2

Page 24: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

2935 CH2 / BB & 2935 CH2 / AS Ratio Drifts of 2

HPMCAS Samples with Elution Time (MWD)

SE2

ES1

ES1

SE2

Peak 2935 / AS

Peak 2935 / BB

Page 25: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

Small HP/AS Ratio Drifts of 2 HPMCAS Samples

with Elution Time (MWD)

ES1

SE2

Page 26: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

Backbone/AS & HP/AS Ratio Drifts of 2 HPMCAS

Samples with Elution Time

SE2

ES1

SE2

ES1

BB / AS

HP / AS

Page 27: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

OH/AS Ratio Drifts of 2 HPMCAS Samples with

Elution Time (MWD)

SE2

ES1

Page 28: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

Methoxy/AS C=O Ratio Drifts of

2 HPMCAS Samples with Elution Time (MWD)

SE2

ES1

Page 29: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

Acetyl/AS C=O Ratio Drifts of

2 HPMCAS Samples with Elution Time (MWD)

SE2

ES1

0.52 ---- MF

0.40 ---- LF

Grade

Levels

Page 30: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

Methoxy/2935 CH2 & Methoxy/Backbone Ratio

Drafts of 2 HPMCAS Samples with Elution Time

M / 2935 CH2

M / BB

ES1

SE2

ES1

SE2

Page 31: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

Methoxy / Acetyl Ratio Drafts of

2 HPMCAS Samples with Elution Time (MWD)

ES1

SE2

Page 32: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

Summary: Compositional Differences

of 2 HPMCAS Samples

32

Sample # Sample

Appearance

Compositional Drifts

w/ MWD

Consistent

Substitution

w/ MWD

ES1 Fine

Powder

Methoxy,

Acetyl / Succinate,

Hydroxyl, CH2

HP

SE2 Fine

Powder

Methoxy,

Acetyl / Succinate,

Hydroxyl, CH2

HP

Difference

Different Drift Patterns

with Methoxy,

Acetyl / Succinate,

Hydroxyl, CH2

Little

Difference

with HP

Page 33: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

GPC-IR Chromatogram Overlay

at 1739 cm-1 of 4 HPMCAS-MF Lots

T8 T10 T12 T14 Snapshots

Page 34: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

Acetyl/TotalEster Ratio Drifts of 4 MF Lots

Compared to LF & HF HPMCAS

-- LF ---------

-- HF ---------

Page 35: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

GPC-IR Conclusions

GPC-IR Takes Snapshot IR Pictures of Polymer Excipients

for Compositional Drifts with MW Distributions

Many Ways to Analyze Functional Group Drifts w/ MWD:

Group vs. Backbone, Various Ratios among Groups, etc.

Useful to Characterize Lot-to-Lot, Grade-to-Grade and

Supplier-to-Supplier Variations of Polymeric Excipients

Understand Excipient Manufacturing Variables and QC

GPC-IR is a Powerful Tool to Analyze Compositional

Variations of Copolymers across MWD

Page 36: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

Common Polymeric Excipients

36

Neutral Cellulose Derivatives

• HydroxyPropyl Methoxy Cellulose (Hypromellose): HPMC

• HydroxyPropyl Cellulose: HPC

• Cellulose Acetate Butyrate: CAB

Acidic Cellulose Derivatives

• HPMC Acetate Succinate: HPMC-AS

• HPMC Phthalate: HPMC-P

• Cellulose Acetate Phthalate: C-A-P

Copovidone: PolyVinyl Pyrrolidone / Vinyl Acetate – PVP/VAc

SoluPlus Terpolymer: PEG / PCL / PVAc

Methacrylate Copolymers: Eudragit

Polyethylene Oxide: PEO (MW > 20K) or PEG (MW < 20K)

Excipient Combinations with Plasticizers and Additives

Page 37: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

Excipient Analysis with LC-IR

in Drug Formulations

• Polymeric Excipient Characterization

• Degradation in Process (Hot Melt Extrusion)

• Excipient / API Interactions

• Forced Degradation in Shelf Life Study

December 1, 2008: Vol. 5, No. 6

The cover cartoon illustrates a solid dispersion assembly that is

composed of entangled polymer chains with drug molecules

embedded in the form of single molecule, small clusters, and/or

large aggregates (amorphous).

Page 38: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

GPC-IR Applications for Excipient Analysis

in Drug Formulations

Excipient

Manufacturing

• Process Control

• Lot-to-lot Variations

• CoA

• Novel Excipient R&D

• Trouble Shooting

Formulation Develop. Drug Manufacturing

• Incoming QC

• Excipient Functionality

• Formulation Development

• QbD

• Process Degradation (Hot Melt Extrusion)

• Define Safe Process Window / QbD

• Process Monitoring

• Trouble Shooting

Formulated Drugs

Shelf Life Stability

• Stressed Degradation

• De-Formulate Excipient Blends

• Trouble-Shoot Problem Drugs in the Market

Users: Excipient Pharma Co. Pharma Co.

Manufacturers HME Service Providers Generic Drug Co.

Page 39: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

Excipient QbD Space

GPC-IR-Performance

Slide from USP International Excipient Workshop (July 2009)

GPC

IR

Performance

Page 40: HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR

GPC-IR & HPLC-IR Applications

Excipient Characterization, Functionality & Degradation Analysis

Copolymer Compositional Analysis across MW Distribution

Polyolefin Copolymer Branching Analysis by High Temp GPC-IR

Polymer Blend Ratio Analysis across MW Distribution

Polymer Additive & Impurity Analysis

De-Formulation for Polymers and Additives: Competitive Analysis

Process Control & Optimization

Excipients, Plastics, Rubbers, Films, Fibers, Foams & Composites

Reactive Polymer Analysis for Coating, Adhesive, Sealant & Elastomer

Isomer Analysis for Chemicals, Forensics & Pharmaceuticals

General Analytical Capability: Trouble Shooting

40